NZX-listed drug maker AFT Pharmaceuticals today announced a downgrade in its earnings guidance for the 2021 financial year.
AFT said in a market announcement, it expects an operating profit between $9 million and $11m, compared with the prior year’s equivalent figure of $11.4m and well
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
